Laboratory Testing for Adult Patients of Child-Bearing Potential Presenting Emergently
For an adult patient of child-bearing potential presenting emergently, obtain a pregnancy test immediately, followed by a comprehensive panel including complete blood count, urinalysis, blood type and screen, screening for rubella, syphilis, hepatitis B, HIV, gonorrhea, chlamydia, and diabetes. 1
Core Laboratory Panel
The following tests should be drawn based on established preconception care guidelines:
Essential Screening Tests
- Complete blood count (CBC) - screens for anemia and other hematologic abnormalities that could affect pregnancy outcomes 1
- Urinalysis - identifies urogenital infections and renal abnormalities 1
- Blood type and screen - critical for identifying Rh incompatibility and potential need for RhoGAM 1
Infectious Disease Screening
- Rubella immunity - essential as infection during pregnancy causes severe birth defects 1
- Syphilis screening - prevents congenital syphilis 1
- Hepatitis B surface antigen - identifies chronic carriers who require specific management 1
- HIV screening - allows for antiretroviral therapy to prevent vertical transmission 1
- Gonorrhea and chlamydia testing - treats infections that can cause adverse pregnancy outcomes 1
Metabolic Screening
- Diabetes screening (fasting glucose or HbA1c) - identifies pre-existing diabetes requiring optimization before conception 1
Additional Considerations for Emergency Presentations
Age-Related Testing
Emergently presenting patients tend to be older and have higher rates of metabolic abnormalities, so consider adding: 2
- Basic metabolic panel (BUN, creatinine, electrolytes, glucose) - emergently presenting patients show higher rates of abnormal renal function and glucose 2
- Liver function tests (AST, ALT) - emergently presenting patients demonstrate significantly higher rates of hepatic enzyme abnormalities 2
Clinical Context-Specific Testing
- Electrocardiogram - emergently presenting patients show prolonged QTc intervals more frequently 2
- Coagulation studies (PT, aPTT, bleeding time, platelet count) if bleeding history or concern for coagulopathy 3
Critical Timing Considerations
The pregnancy test is paramount because organogenesis begins extremely early - neural tube closure occurs at 6 weeks (28 days post-conception), and placental development starts at implantation (7 days post-conception). 1 Any teratogenic exposures or interventions after the first prenatal visit may be too late to prevent birth defects or placental abnormalities. 1
Common Pitfalls
- Failing to obtain pregnancy test first - this single test fundamentally changes management of nearly every emergency condition and medication choice
- Delaying infectious disease screening - these tests guide immediate treatment decisions and prophylaxis needs
- Omitting diabetes screening - uncontrolled hyperglycemia during early pregnancy significantly increases birth defect risk 1